Shaocheng Zeng
机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, Jiangxi Provincial Cancer Hospital · ORCID：0009-0008-3128-0523
发表论文 4 篇 · 总被引 177 次 · h-index 4
代表论文
- Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment (2023 · Molecular Cancer · 被引 121)
- Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer (2023 · Frontiers in Immunology · 被引 33)
- MDM2 inhibitors in cancer immunotherapy: Current status and perspective (2024 · Genes & Diseases · 被引 18)
- YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression (2024 · Cellular and Molecular Life Sciences · 被引 6)